Credo Technology Group Holding Ltd vs Twist Bioscience Corp — how do they compare? Credo Technology Group Holding Ltd trades at $256 (market cap $46.19B), while Twist Bioscience Corp trades at $124 (market cap $7.72B). The key difference: Credo Technology Group Holding Ltd is far larger — about 6× Twist Bioscience Corp's market cap, and Twist Bioscience Corp is trading nearer its 52-week high, Credo Technology Group Holding Ltd nearer its low. Which is the better fit depends on your goals.
| CRDO | TWST | |
|---|---|---|
Market Cap | $46.19B | $7.72B |
Sector | Technology | Health |
52-Week High | $302.52 | $124.88 |
52-Week Low | $87.81 | $24.16 |
Enterprise Value | $44.77B | $7.65B |
Trailing returns across standard periods
Latest headlines on both assets
Credo Technology provides high-speed connectivity solutions for AI-driven applications and hyperscale data centers. Its products enable faster, more energy-efficient data transmission for cloud and telecom infrastructure.
Read more on CRDO →Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →